ENTITY

Mayinglong Pharmaceutical A (600993 CH)

Analysis

Health Care • China

Mayinglong Pharmaceutical Group Company Limited manufactures and markets traditional Chinese medicines and western medicines for the treatment of hemorrhoids and cough.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00